Close Menu

NEW YORK (GenomeWeb) – PathoQuest, announced today that it has partnered with Mayo Clinic to study the company's iDtect Blood test in order to improve the diagnosis of neutropenic fever in patients.  

As part of the collaboration, the Mayo Clinic will apply the next-generation sequencing-based metagenomic test in a prospective study designed to validate its utility.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.